ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001404553

Invus Advisors, L.L.C.

CIK 0001404553 Name as filed on the most recent filing

Filed as Invus Advisors, L.L.C. (23)

44 transaction lines · from 23 filings · filed 2007-08-24 to 2023-06-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2023-06-05 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 27,775,050 acquired 2.60 72,215,130.00 Form 4, filing 0000899243-23-014464
2022-08-05 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 2,426,070 acquired 2.50 6,065,175.00 Form 4, filing 0000899243-22-028108
2022-08-01 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 16,173,800 acquired 2.50 40,434,500.00 Form 4, filing 0000899243-22-027156
2020-12-16 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 10,937,500 acquired 3.20 35,000,000.00 Form 4, filing 0000899243-20-034268
2018-06-28 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 57,724 acquired 12.45 718,935.10 Form 4, filing 0000899243-18-018727
2018-06-27 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 125,114 acquired 12.54 1,568,441.62 Form 4, filing 0000899243-18-018727
2018-06-25 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 228,264 acquired 12.95 2,955,082.92 Form 4, filing 0000899243-18-018161
2018-06-22 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 25,461 acquired 13.36 340,090.22 Form 4, filing 0000899243-18-018161
2018-06-21 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 51,600 acquired 13.27 684,613.32 Form 4, filing 0000899243-18-017617
2018-06-20 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 12,391 acquired 13.28 164,613.20 Form 4, filing 0000899243-18-017617
2018-06-19 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 8,982 acquired 13.45 120,818.68 Form 4, filing 0000899243-18-017617
2018-06-18 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 36,584 acquired 13.06 477,937.03 Form 4, filing 0000899243-18-017071
2018-06-14 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 9,200 acquired 12.66 116,461.88 Form 4, filing 0000899243-18-017071
2018-06-12 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 107,023 acquired 12.83 1,373,244.22 Form 4, filing 0000899243-18-016245
2018-06-11 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 98,626 acquired 12.75 1,257,451.91 Form 4, filing 0000899243-18-016245
2018-06-08 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 29,747 acquired 12.89 383,426.93 Form 4, filing 0000899243-18-016245
2018-06-07 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 57,439 acquired 12.93 742,508.21 Form 4, filing 0000899243-18-015606
2018-06-06 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 95,079 acquired 12.58 1,196,369.55 Form 4, filing 0000899243-18-015606
2018-06-05 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 173,121 acquired 12.45 2,156,187.43 Form 4, filing 0000899243-18-015606
2018-06-04 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 121,803 acquired 12.24 1,490,576.39 Form 4, filing 0000899243-18-014948
2018-06-01 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 147,339 acquired 12.22 1,800,040.56 Form 4, filing 0000899243-18-014948
2018-05-31 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 147,339 acquired 11.62 1,712,049.71 Form 4, filing 0000899243-18-014948
2018-05-30 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 147,339 acquired 10.32 1,521,024.70 Form 4, filing 0000899243-18-014494
2018-05-29 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 147,339 acquired 9.84 1,450,419.85 Form 4, filing 0000899243-18-014494
2018-05-25 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 138,700 acquired 9.62 1,334,973.63 Form 4, filing 0000899243-18-014494
2017-11-17 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 50,000 acquired 9.85 492,500.00 Form 4, filing 0000899243-17-026881
2017-11-15 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 130,727 acquired 10.21 1,334,395.85 Form 4, filing 0000899243-17-026881
2017-11-14 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 215,133 acquired 9.47 2,037,847.34 Form 4, filing 0000899243-17-026246
2017-11-13 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 215,133 acquired 9.75 2,097,933.99 Form 4, filing 0000899243-17-026246
2017-11-10 Lexicon Pharmaceuticals, Inc.
LXRX 		P, Open-market purchase 145,680 acquired 9.74 1,418,384.18 Form 4, filing 0000899243-17-026246
2016-09-16 Blue Buffalo Pet Products, Inc.
BUFF 		S, Open-market sale 12,512,124 disposed 24.83 310,642,256.19 Form 4, filing 0000899243-16-029167
2016-07-05 Blue Buffalo Pet Products, Inc.
BUFF 		S, Open-market sale 15,014,548 disposed 21.28 319,584,654.18 Form 4, filing 0000899243-16-024751
2015-07-27 Blue Buffalo Pet Products, Inc.
BUFF 		S, Open-market sale 28,464,603 disposed 20.00 569,292,060.00 Form 4, filing 0000899243-15-001726
2014-11-26 Lexicon Pharmaceuticals, Inc./DE
LXRX 		P, Open-market purchase 149,253,731 acquired 1.00 149,999,999.66 Form 4, filing 0001209191-14-071632
2012-10-23 Lexicon Pharmaceuticals, Inc./DE
LXRX 		P, Open-market purchase 3,000,000 acquired 2.25 6,750,000.00 Form 4, filing 0001181431-12-055549
2010-03-19 Lexicon Pharmaceuticals, Inc./DE
LXRX 		P, Open-market purchase 59,296,749 acquired 1.15 68,191,261.35 Form 4, filing 0001181431-10-017475
2010-03-19 Lexicon Pharmaceuticals, Inc./DE
LXRX 		P, Open-market purchase 29,021,739 acquired 1.15 33,374,999.85 Form 4, filing 0001181431-10-017475
2010-03-19 Lexicon Pharmaceuticals, Inc./DE
LXRX 		P, Open-market purchase 5,190,848 acquired 1.15 5,969,475.20 Form 4, filing 0001181431-10-017475
2010-03-19 Lexicon Pharmaceuticals, Inc./DE
LXRX 		P, Open-market purchase 760,870 acquired 1.15 875,000.50 Form 4, filing 0001181431-10-017475
2009-10-15 Lexicon Pharmaceuticals, Inc./DE
LXRX 		P, Open-market purchase 2,015,888 acquired 1.50 3,023,832.00 Form 4, filing 0001181431-09-047797
2009-10-14 Lexicon Pharmaceuticals, Inc./DE
LXRX 		P, Open-market purchase 13,439,257 acquired 1.50 20,158,885.50 Form 4, filing 0001181431-09-047797
2008-04-30 Lexicon Pharmaceuticals, Inc./DE
LXRX 		P, Open-market purchase 669,052 acquired 2.00 1,338,104.00 Form 4, filing 0001181431-08-028285

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Invus Advisors, L.L.C., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001404553

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.